The clinical significance of equivocal findings on spinal MRI in children with medulloblastoma

被引:10
作者
Bennett, Julie [1 ]
Ashmawy, Ramy [2 ]
Ramaswamy, Vijay [1 ]
Stephens, Derek [3 ]
Bouffet, Eric [1 ]
Laperriere, Normand [4 ]
Taylor, Michael [5 ]
Shroff, Manohar [2 ]
Bartels, Ute [1 ]
机构
[1] Univ Toronto, Hosp Sick Children, Div Hematol Oncol, Dept Paediat, Toronto, ON, Canada
[2] Univ Toronto, Hosp Sick Children, Dept Diagnost Imaging, Div Neuroradiol, Toronto, ON, Canada
[3] Hosp Sick Children, Div Clin Res Serv, Res Inst, Toronto, ON, Canada
[4] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON, Canada
[5] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada
关键词
medulloblastoma; MRI; staging; GADOPENTETATE DIMEGLUMINE; BRAIN-TUMORS; CSF CYTOLOGY; NERVE ROOTS; RECURRENCE; SUBGROUPS; RESECTION; SURGERY;
D O I
10.1002/pbc.26472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMedulloblastoma (MB) is the most common malignant brain tumor of childhood, with cerebrospinal fluid spread the most common site of metastasis. Currently, children diagnosed with MB and evidence of spinal metastasis are treated with an increased dose of craniospinal radiation (CSI). This report reviewed equivocal abnormalities including nerve root clumping, linear vascular enhancement, nerve root enhancement and/or other vague findings on spinal magnetic resonance imaging (MRI) to elucidate their prognostic significance and aid in risk stratification. MethodsThis retrospective cohort study identified children (3 years) diagnosed with MB between 1988 and 2012. Children treated with upfront CSI were included, and staging spine MRI must have been done preoperatively or within 72 hr of primary tumor resection. Initial MRI of the spine was assessed by two independent reviewers blinded to outcome to evaluate for equivocal findings. Survival analysis was done to determine impact on prognosis. ResultsOne hundred of 157 patients were eligible for the analysis. Equivocal findings were identified in 48 (48%) patients, with MRI done preoperatively in 45 (94%) patients. Analysis by subgroup identified a higher proportion of equivocal findings in the sonic hedgehog (SHH) subgroup (P = 0.007). Five-year overall survival (OS) in children with equivocal findings compared to those with normal MRI was not different, 80 vs. 84.8% respectively, while OS in M3 patients was worse at 54.7% (P = 0.02). ConclusionA higher proportion of equivocal findings was identified in the SHH subgroup. This institutional retrospective review demonstrates equivocal findings are common, not associated with decreased OS and should not prompt increased dose of CSI.
引用
收藏
页数:6
相关论文
共 19 条
  • [11] MEYERS SP, 1994, AM J NEURORADIOL, V15, P1425
  • [12] Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
    Northcott, Paul A.
    Shih, David J. H.
    Remke, Marc
    Cho, Yoon-Jae
    Kool, Marcel
    Hawkins, Cynthia
    Eberhart, Charles G.
    Dubuc, Adrian
    Guettouche, Toumy
    Cardentey, Yoslayma
    Bouffet, Eric
    Pomeroy, Scott L.
    Marra, Marco
    Malkin, David
    Rutka, James T.
    Korshunov, Andrey
    Pfister, Stefan
    Taylor, Michael D.
    [J]. ACTA NEUROPATHOLOGICA, 2012, 123 (04) : 615 - 626
  • [13] Medulloblastoma Comprises Four Distinct Molecular Variants
    Northcott, Paul A.
    Korshunov, Andrey
    Witt, Hendrik
    Hielscher, Thomas
    Eberhart, Charles G.
    Mack, Stephen
    Bouffet, Eric
    Clifford, Steven C.
    Hawkins, Cynthia E.
    French, Pim
    Rutka, James T.
    Pfister, Stefan
    Taylor, Michael D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) : 1408 - 1414
  • [14] Ozerov S S, 2015, Zh Vopr Neirokhir Im N N Burdenko, V79, P72, DOI 10.17116/neiro201579572-76
  • [15] Ozerov SS, 2015, ZH VOPR NEIROKHIR IM, V79, P76
  • [16] Packer RJ, 2012, HAND CLINIC, V105, P529, DOI 10.1016/B978-0-444-53502-3.00007-0
  • [17] Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis
    Patel, Swetal
    Bhatnagar, Amit
    Wear, Christopher
    Osiro, Stephen
    Gabriel, Abigail
    Kimball, David
    John, Alana
    Fields, Paul J.
    Tubbs, R. Shane
    Loukas, Marios
    [J]. CHILDS NERVOUS SYSTEM, 2014, 30 (01) : 147 - 154
  • [18] Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
    Ramaswamy, Vijay
    Remke, Marc
    Et, Eric Bouff
    Faria, Claudia C.
    Perreault, Sebastien
    Cho, Yoon-Jae
    Shih, David J.
    Luu, Betty
    Dubuc, Adrian M.
    Northcott, Paul A.
    Schueller, Ulrich
    Gururangan, Sridharan
    McLendon, Roger
    Bigner, Darell
    Fouladi, Maryam
    Ligon, Keith L.
    Pomeroy, Scott L.
    Dunn, Sandra
    Triscott, Joanna
    Jabado, Nada
    Fontebasso, Adam
    Jones, David T. W.
    Kool, Marcel
    Karajannis, Matthias A.
    Gardner, Sharon L.
    Zagzag, David
    Nunes, Sofi A.
    Pimentel, Jose
    Mora, Jaume
    Lipp, Eric
    Walter, Andrew W.
    Ryzhova, Marina
    Zheludkova, Olga
    Kumirova, Ella
    Alshami, Jad
    Croul, Sidney E.
    Rutka, James T.
    Hawkins, Cynthia
    Tabori, Uri
    Codispoti, Kari-Elise T.
    Packer, Roger J.
    Pfister, Stefan M.
    Korshunov, Andrey
    Taylor, Michael D.
    [J]. LANCET ONCOLOGY, 2013, 14 (12) : 1200 - 1207
  • [19] Molecular subgroups of medulloblastoma: the current consensus
    Taylor, Michael D.
    Northcott, Paul A.
    Korshunov, Andrey
    Remke, Marc
    Cho, Yoon-Jae
    Clifford, Steven C.
    Eberhart, Charles G.
    Parsons, D. Williams
    Rutkowski, Stefan
    Gajjar, Amar
    Ellison, David W.
    Lichter, Peter
    Gilbertson, Richard J.
    Pomeroy, Scott L.
    Kool, Marcel
    Pfister, Stefan M.
    [J]. ACTA NEUROPATHOLOGICA, 2012, 123 (04) : 465 - 472